UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 842

Sortiert nach

Clinical management of uterine sarcomas

The lancet oncology, 2009-12, Vol.10 (12), p.1188-1198

2009

Volltextzugriff (PDF)

Trial watch: dendritic cell vaccination for cancer immunotherapy

Oncoimmunology, 2019-11, Vol.8 (11), p.e1638212-e1638212

2019

Volltextzugriff (PDF)

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification

Genome medicine, 2021-07, Vol.13 (1), p.111-111, Article 111

2021

Volltextzugriff (PDF)

Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses

Clinical cancer research, 2017-05, Vol.23 (9), p.2223-2231

2017

Volltextzugriff (PDF)

A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncology

Oncoimmunology, 2022-12, Vol.11 (1), p.2024692-2024692

2022

Volltextzugriff (PDF)

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Frontiers in immunology, 2015-11, Vol.6, p.588-588

2015

Volltextzugriff (PDF)

Editorial: Challenges associated with identifying preclinical animal models for the development of immune-based therapies

Frontiers in immunology, 2024-03, Vol.15, p.1404085-1404085

2024

Volltextzugriff (PDF)

Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy

Frontiers in immunology, 2023-09, Vol.14, p.1236965-1236965

2023

Volltextzugriff (PDF)

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer

Oncoimmunology, 2022-12, Vol.11 (1), p.2096363-2096363

2022

Volltextzugriff (PDF)

Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer

Cancers, 2022-08, Vol.14 (16), p.4037

2022

Volltextzugriff (PDF)

Liquid Biopsy in Glioblastoma

Cancers, 2022-07, Vol.14 (14), p.3394

2022

Volltextzugriff (PDF)

Simultaneous in vivo PET/MRI using fluorine-18 labeled Fe3O4@Al(OH)3 nanoparticles: comparison of nanoparticle and nanoparticle-labeled stem cell distribution

EJNMMI research, 2020-06, Vol.10 (1), p.73-73, Article 73

2020

Volltextzugriff (PDF)

Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates

Pharmaceutics, 2023-06, Vol.15 (7), p.1792

2023

Volltextzugriff (PDF)

Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma

Cancers, 2020-12, Vol.13 (1), p.19

2020

Volltextzugriff (PDF)

Trial watch: chemotherapy-induced immunogenic cell death in oncology

Oncoimmunology, 2023-12, Vol.12 (1), p.2219591-2219591

2023

Volltextzugriff (PDF)

Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer

Translational oncology, 2020-03, Vol.13 (3), p.100743-100743, Article 100743

2020

Volltextzugriff (PDF)

Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors

International journal of gynecological cancer, 2019-11, Vol.29 (9), p.1381-1388

2019

Volltextzugriff (PDF)

Type of chemotherapy has substantial effects on the immune system in ovarian cancer

Translational oncology, 2021-06, Vol.14 (6), p.101076-101076, Article 101076

2021

Volltextzugriff (PDF)

TIM3 Checkpoint Inhibition Fails to Prolong Survival in Ovarian Cancer-Bearing Mice

Cancers, 2024-03, Vol.16 (6), p.1147

2024

Volltextzugriff (PDF)

Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer

Cancers, 2021-11, Vol.13 (23), p.5899

2021

Volltextzugriff (PDF)

Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance

Frontiers in oncology, 2024-06, Vol.14, p.1402851

2024

Volltextzugriff (PDF)

CryptoCEST: A promising tool for spatially resolved identification of fungal brain lesions and their differentiation from brain tumors with MRI

NeuroImage clinical, 2021-01, Vol.31, p.102737-102737, Article 102737

2021

Volltextzugriff (PDF)

Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines

Oncoimmunology, 2022-12, Vol.11 (1), p.2101596-2101596

2022

Volltextzugriff (PDF)

Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer

Npj genomic medicine, 2022-04, Vol.7 (1), p.30-30, Article 30

2022

Volltextzugriff (PDF)

1 – 25 von 842

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(726)
Mit Volltextzugriff
(704)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(519)
Life Sciences & Biomedicine
(422)
Humans
(299)
Female
(191)
Biological And Medical Sciences
(165)
Male
(154)
Animals
(142)
Surgery
(140)
Middle Aged
(127)
Medical Sciences
(117)
Adult
(107)
Tropical Medicine
(79)
Technology
(77)
Aged
(75)
Infectious Diseases
(67)
Malaria
(67)
Parasitology
(62)
Fundamental And Applied Biological Sciences. Psychology
(61)
Treatment Outcome
(61)
Oncology
(59)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Clinical management of uterine sarcomas

Trial watch: dendritic cell vaccination for cancer immunotherapy

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification

Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses

A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncology

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Editorial: Challenges associated with identifying preclinical animal models for the development of immune-based therapies

Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer

Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer

Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative

Liquid Biopsy in Glioblastoma

Simultaneous in vivo PET/MRI using fluorine-18 labeled Fe3O4@Al(OH)3 nanoparticles: comparison of nanoparticle and nanoparticle-labeled stem cell distribution

Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates

Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma

Trial watch: chemotherapy-induced immunogenic cell death in oncology

Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer

Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors

Type of chemotherapy has substantial effects on the immune system in ovarian cancer

TIM3 Checkpoint Inhibition Fails to Prolong Survival in Ovarian Cancer-Bearing Mice

Neo-Adjuvant Chemotherapy Reduces, and Surgery Increases Immunosuppression in First-Line Treatment for Ovarian Cancer

Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance

CryptoCEST: A promising tool for spatially resolved identification of fungal brain lesions and their differentiation from brain tumors with MRI

Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines

Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer

Suchergebnisse filtern